⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Louis CubbaMD

Internal Medicine · San Francisco, CA 94114

NPI: 1649201716

Share:

30

🟠 Elevated

Risk Flags

Extreme cost outlier (population + peer)High long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)High fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

7,377

Total Claims

$5.6M

Drug Cost

323

Beneficiaries

$17K

Cost/Patient

Risk Score Breakdown 30/100

Low (0)Moderate (15)Elevated (30)High (50+)
Cost per patient outlier+10
Long-acting opioid rate+8
Elderly antipsychotic prescribing+5
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+18%

Opioid rate vs peers

2.6% vs 2.2% avg

+1139%

Cost per patient vs peers

$17K vs $1,411 avg

+158%

Brand preference vs peers

27.5% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

💰

Cost per patient is 1139% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

2.6%

Opioid Rate

195

Opioid Claims

$60K

Opioid Cost

28.2%

Long-Acting Rate

Brand vs Generic

73% generic

Brand: 2,018 claims · $5.4M

Generic: 5,331 claims · $275K

Patient Profile

71

Avg Age

9%

Female

1.18

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About